Cytotoxic T-Lymphocyte Epitope Vaccination Protects against Human Metapneumovirus Infection and Disease in Mice

Immunology and Microbiology

• Human metapneumovirus 100%
• Cytotoxic T Cell 100%
• Epitope 100%
• Infection 100%
• Peptides 16%
• Human respiratory syncytial virus 16%
• T Cell 16%
• Cytokine 16%
• Interleukin 10 8%
• Infectious Agent 8%
• Allele 8%
• Cell Assay 8%
• Immunopathology 8%
• Lower Respiratory Tract 8%
• Lymph Node 8%
• Viral Load 8%
• Bioinformatics 8%
• Upper Respiratory Tract 8%
• Interleukin 12 8%
• Interleukin 4 8%
• Asthma Exacerbation 8%
• Interferon Gamma 8%
• Major Histocompatibility Complex 8%

Keyphrases

• Vaccination 100%
• Cytotoxic T Lymphocyte Epitope 100%
• Human Metapneumovirus (hMPV) 100%
• Young children 16%
• Lung 16%
• Human Respiratory Syncytial Virus (hRSV) 16%
• Peptide Immunization 16%
• Upper Respiratory Tract Infection 8%
• Interleukin-10 8%
• MHC Class II 8%
• Older Adults 8%
• Interferon-γ 8%
• Immunopathology 8%
• Asthma Exacerbation 8%
• Mouse T Cells 8%
• Th2 Cytokines 8%
• Bioinformatics 8%
• T Cell Assay 8%
• Viral Load 8%
• Epidemiological Evidence 8%
• Murine Model 8%
• Interleukin-12 (IL-12) 8%
• Regional Lymph Nodes 8%
• Clinical Disease 8%
• Young-old 8%
• Th1 Cytokines 8%
• Class I Alleles 8%
• Respiratory Pathogens 8%
• Epitope Vaccine 8%
• Human Respiratory Tract 8%
• Lower Respiratory Tract Infection 8%
• Interleukin-4 (IL-4) 8%
• HLA-A*0201 8%